Company: ALM
Filing Date: 2025-07-07
Form Type: F-10
Source: 0001641172-25-017947
Chunk: 59

Company: Almonty Industries Inc.
Filing Date: 2025-07-07
Form: F-10
Chunk 59
---
 with research capabilities do not follow the Company’s securities; lessening
in trading volume and general market interest in the Company’s securities may affect an investor’s ability to trade significant
numbers of securities of the Company; the size of the Company’s public float may limit the ability of some institutions to invest
in the Company’s securities; and a substantial decline in the price of the securities of the Company that persists for a significant
period of time could cause the Company’s securities to be delisted from an exchange on which they are traded, further reducing
market liquidity.

| 32 |

Securities class-action
litigation often has been brought against companies following periods of volatility in the market price of their securities. The Company
may in the future be the target of similar litigation. Securities litigation could result in substantial costs and damages and divert
management’s attention and resources.

Dilution to the Company’s Shareholders

The Company may sell
equity securities in public offerings (including through the sale of securities convertible into equity securities) and may issue additional
equity securities to finance operations, exploration, development, project construction, acquisitions or other projects. The Company
cannot predict the size of future issuances of equity securities or the size and terms of future issuances of debt instruments or other
securities convertible into equity securities or the effect, if any, that future issuances and sales of the Company’s securities
will have on the market price of the Common Shares. Any transaction involving the issuance of previously authorized but unissued Common
Shares, or securities convertible into Common Shares, would result in dilution, possibly substantial, to security holders. Exercises
of presently outstanding convertible securities of the Company may also result in dilution to security holders. See “Consolidated Capitalization”.

The board of directors
of the Company (the “Board”) has the authority to authorize certain offers and sales of additional securities without
the vote of, or prior notice to, shareholders. Based on the need for additional capital to fund expected expenditures and growth, the
Company may issue additional securities to provide such capital. Such additional issuances may involve the issuance of a significant
number of Common Shares at prices less than the current market price for the Common Shares.

Sales of substantial
amounts of the Company’s securities, or the availability of such securities for sale, could adversely affect the prevailing market
prices for the Company’s securities and dilute investors’ earnings per share. A decline in the market prices of Company’s
securities could impair the Company